03 Nov 2025 | 3 Mins Read
Ajanta Pharma reports 20% profit increase
Flipitmoney
Ajanta Pharma Ltd's consolidated net profit rose 20% YoY to ₹260 crore in the September quarter, with revenue up 14% to ₹1,354 crore. EBITDA stood at ₹328 crore, up 5%. The company approved a ₹28 per equity share dividend for FY26, amounting to ₹349.82 crore, with a record date of November 10 and payment on or after November 20, 2025.